Literature DB >> 28941671

Outcomes of Emergency Department Anaphylaxis Visits from 2005 to 2014.

Megan S Motosue1, M Fernanda Bellolio2, Holly K Van Houten3, Nilay D Shah4, James T Li1, Ronna L Campbell5.   

Abstract

BACKGROUND: Although the incidence of anaphylaxis appears to be increasing, trends in anaphylaxis-related health care utilization are not well understood.
OBJECTIVE: To better understand the potential increasing health care burden, we analyzed the changes in anaphylaxis-related health care utilization, including emergency department (ED) discharges, observation stays, inpatient admissions, intensive care unit admissions, and endotracheal intubations.
METHODS: We conducted an observational study examining outcomes of anaphylaxis-related ED visits between January 1, 2005, and December 31, 2014. We analyzed administrative claims data from OptumLabs Data Warehouse, which includes more than 100 million Medicare Advantage and privately insured enrollees in the United States. We studied trends in the proportions of ED-related anaphylaxis visits based on demographic characteristics, triggers, and ED disposition for our study population.
RESULTS: Among 56,212 anaphylaxis-related ED visits during a 10-year period, the proportion of patient observation/inpatient admissions increased by 37.6% (P = .02), from 13.2% of anaphylaxis-related ED visits in 2005 to 18.2% in 2014. The proportion of patients admitted to the intensive care unit increased by 27.4% (P = .001), from 4.5% in 2005 to 5.8% in 2014. Proportions of endotracheal intubation increased by 145.2% (P < .001).
CONCLUSIONS: The increasing proportions of observation/inpatient admissions, intensive care unit admissions, and endotracheal intubations suggest an increase in anaphylaxis severity. Enhanced awareness of these trends among patients, practitioners, and the community is necessary to create effective strategies to prevent anaphylaxis and decrease associated adverse consequences.
Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaphylaxis; Hospitalization; Trends; United States

Mesh:

Year:  2017        PMID: 28941671     DOI: 10.1016/j.jaip.2017.07.041

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  7 in total

1.  Development and validation of an algorithm to identify drug-induced anaphylaxis in the Beijing Pharmacovigilance Database.

Authors:  Ying Zhao; Haidong Lu; Sydney Thai; Xiaotong Li; John Hui; Huilin Tang; Suodi Zhai; Lulu Sun; Tiansheng Wang
Journal:  Int J Clin Pharm       Date:  2018-02-20

Review 2.  Anaphylaxis: Data Gaps and Research Needs.

Authors:  Timothy E Dribin; Mariana Castells
Journal:  Immunol Allergy Clin North Am       Date:  2022-02       Impact factor: 3.152

3.  Drug-Related Hypersensitivity Reactions Leading to Emergency Department: Original Data and Systematic Review.

Authors:  Silvia Pagani; Niccolò Lombardi; Giada Crescioli; Violetta Giuditta Vighi; Giulia Spada; Paola Andreetta; Annalisa Capuano; Alfredo Vannacci; Mauro Venegoni; Giuseppe Danilo Vighi
Journal:  J Clin Med       Date:  2022-05-16       Impact factor: 4.964

4.  Identification of children with anaphylaxis at low risk of receiving acute inpatient therapies.

Authors:  Timothy E Dribin; Kenneth A Michelson; Michael C Monuteaux; Anne M Stack; Karen S Farbman; Lynda C Schneider; Mark I Neuman
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

5.  Anaphylaxis in Brazil between 2011 and 2019.

Authors:  Luciana Kase Tanno; Nicolas Molinari; Isabella Annesi-Maesano; Pascal Demoly; Ana Luiza Bierrenbach
Journal:  Clin Exp Allergy       Date:  2022-07-20       Impact factor: 5.401

Review 6.  Myths, facts and controversies in the diagnosis and management of anaphylaxis.

Authors:  Katherine Anagnostou; Paul J Turner
Journal:  Arch Dis Child       Date:  2018-06-16       Impact factor: 3.791

7.  Global Trends in Anaphylaxis Epidemiology and Clinical Implications.

Authors:  Paul J Turner; Dianne E Campbell; Megan S Motosue; Ronna L Campbell
Journal:  J Allergy Clin Immunol Pract       Date:  2019-11-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.